China Universal Asset Management »

Jazz Pharmaceuticals shares owned by China Universal Asset Management

Quarter-by-quarter ownership of Jazz Pharmaceuticals (JAZZ) shares owned by China Universal Asset Management from 13F filings

Historical chart of China Universal Asset Management investment in Jazz Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Jazz Pharmaceuticals held by China Universal Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Jazz Pharmaceuticals by China Universal Asset Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $1.4M 12k 120.44
2023-12-31 $895k 7.3k 122.94
2023-09-30 $210k 1.6k 129.15
2023-06-30 $104k 839 123.96
2023-03-31 $125k 853 146.54
2022-12-31 $102k 639 159.62
2022-09-30 $78k 587 132.88

More positions owned by China Universal Asset Management

Microsoft Corp Common Stock (MSFT)
Nvidia Corp Common Stock (NVDA)
Amazon.com Common Stock (AMZN)
Meta Platforms Inc-class A Common Stock (META)
Vertex Pharmaceuticals Common Stock (VRTX)
Amgen Common Stock (AMGN)
Servicenow Common Stock (NOW)
Gilead Sciences Common Stock (GILD)
Regeneron Pharmaceuticals Common Stock (REGN)
Alphabet Inc-cl A Common Stock (GOOGL)
Adobe Common Stock (ADBE)
Broadcom Common Stock (AVGO)
Visa Inc-class A Shares Common Stock (V)
Apple Common Stock (AAPL)
Uber Technologies Common Stock (UBER)

View all positions for China Universal Asset Management

Top funds holding Jazz Pharmaceuticals

Vanguard Group
LSV Asset Management
Polaris Capital Management
Jpmorgan Chase & Co
Pacer Advisors
Wellington Management Company
EcoR1 Capital
Franklin Resources
Dimensional Fund Advisors
Samlyn Capital
Millennium Management
Bank of New York Mellon
Thompson, Siegel, & Walmsley
Avidity Partners Management
Bank of America Corporation

View all funds holding Jazz Pharmaceuticals